|
|
24 March 2007 ¡§Primary Health Care: Ask Your Community Pharmacist¡¨
Various studies in the western countries have already demonstrated the importance of pharmacist¡¦s involvement in diseases such as dyslipidaemia and diabetes. To promote public understanding on how community pharmacists help to manage the use of medicines to treat or prevent disease more effectively and efficiently, the School of Pharmacy hosted an informative exhibition on ¡§Primary Health Care - Ask your Community Pharmacist¡¨ on 24-25 March. This two-day event, organised by student members of the Pharmacy Society and co-hosted by Narcotics Division, Security Bureau, demonstrated how you can benefit from the accessibility of your community pharmacist. There were also health talks, health check and counseling, and stall games. ¡§Hong Kong, like many other big cities, is facing the challenge of an ageing population, which is especially vulnerable to side effects of drugs due to non-compliance and/or drug interactions. At the same time, modern medicine is becoming more complex in its mode of action and traditional Chinese medicine is accepted as part of self-care by a rapidly growing segment of the patient population. Both potentially increase the risk of adverse drug reactions. The community pharmacist is in an ideal position to evaluate the compatibility of the two forms of drug therapy in a given patient. Moreover, he/she can advise on the use of self-diagnostic tests to assist in the selection of medicine by the physician and in the quantitative evaluation of progress in drug therapy by the pharmacist,¡¨ said Professor Vincent HL Lee, Director of the School of Pharmacy, CUHK at the opening ceremony. Since the first admission of pharmacy degree students in 1992, CUHK School of Pharmacy has been dedicated to providing Hong Kong society with quality pharmaceutical professionals and preparing our graduates for new career opportunities in this rapidly changing world. They are pursuing their careers in community pharmacy, hospital pharmacy, pharmaceutical companies and the government. |